0001493152-20-019013.txt : 20201006 0001493152-20-019013.hdr.sgml : 20201006 20201006152038 ACCESSION NUMBER: 0001493152-20-019013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201006 DATE AS OF CHANGE: 20201006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dickason David CENTRAL INDEX KEY: 0001827349 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16467 FILM NUMBER: 201226612 MAIL ADDRESS: STREET 1: 126 VALLEY ROAD STREET 2: SUITE C CITY: GLEN ROCK STATE: NJ ZIP: 07452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RespireRx Pharmaceuticals Inc. CENTRAL INDEX KEY: 0000849636 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330303583 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 126 VALLEY ROAD STREET 2: SUITE C CITY: GLEN ROCK STATE: NJ ZIP: 07452 BUSINESS PHONE: (201) 444-4947 MAIL ADDRESS: STREET 1: 126 VALLEY ROAD STREET 2: SUITE C CITY: GLEN ROCK STATE: NJ ZIP: 07452 FORMER COMPANY: FORMER CONFORMED NAME: CORTEX PHARMACEUTICALS INC/DE/ DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2020-09-30 0 0000849636 RespireRx Pharmaceuticals Inc. RSPI 0001827349 Dickason David C/O RESPIRERX PHARMACEUTICALS INC., 126 VALLEY ROAD, SUITE C GLEN ROCK NJ 07452 0 1 0 0 SVP of Pre-Clinical Prod. Dev. Common Stock Options (to purchase shares of Common Stock) 0.0054 2020-09-30 4 A 0 2000000 0.00 A 2025-09-30 Common Stock 2000000 2000000 D These Common Stock Options vest in four equal installments: 25 percent on December 31, 2020, 25 percent on March 31, 2021, 25 percent on June 30, 2021, and 25 percent on September 30, 2021. /s/ David Dickason 2020-10-06